AJMC December 15, 2022
The dilemma of Alzheimer disease in primary care, as well as other health challenges in aging populations, was the focus of a recent Institute for Value-Based Medicine® event in Portland, Oregon.
Am J Accountable Care. 2022;10(4):47-49. https://doi.org/10.37765/ajac.2022.89289
Cognitive concerns frequently show up in primary care as adults age, although not all memory loss will progress to the dysfunction of dementia. However, the number of Americans with diagnosed Alzheimer disease (AD) could grow to nearly 14 million by 2060, up from 6.5 million currently.1
To halt that trend, much of the recent focus has been on the success or failure of drugs to slow the progression of this devastating neurological disease, most notably the FDA’s controversial 2021 approval of aducanumab, a...
Today's Sponsors
Today's Sponsor